Discover
COYA
Coya Therapeutics, Inc.
4.55
1 x 4.52
1 x 5.41
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | -21.55% | |
| 1y | -21.28% |
day range
3.71
52 week range
7.75
| Open | Prev Close | 4.55 | Low | High | Mkt Cap | 82.85M | |||
| Vol | 0.00 | Avg Vol | 203.56K | EPS | -1.12 | P/E | -4.06 | Forward P/E | -4.25 |
| Beta | 0.51 | Short Ratio | 1.53 | Inst. Own | 19.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 4.93 | 200-d Avg | 5.14 | 1yr Est | 15.50 |
| Income Statement | |||
| Total Revenue | 251.15K | ||
| Revenues (USD) | 251.15K | ||
| Gross Profit | 251.15K | ||
| Operating Expenses | 7.89M | ||
| Research and Development Expense | 4.10M | ||
| Selling, General and Administrative Expense | 3.78M | ||
| Operating Income | -7.64M | ||
| Net Income | -7.21M | ||
| Net Income Common Stock | -7.21M | ||
| Net Income Common Stock (USD) | -7.21M | ||
| Consolidated Income | -7.21M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -7.21M | ||
| Earning Before Interest & Taxes (USD) | -7.21M | ||
| Weighted Average Shares | 22.64M | ||
| Weighted Average Shares Diluted | 22.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 50.72M | ||
| Cash and Equivalents (USD) | 50.72M | ||
| Current Assets | 53.26M | ||
| Property, Plant & Equipment Net | 8.42K | ||
| Total Assets | 53.27M | ||
| Current Liabilities | 3.55M | ||
| Total Liabilities | 4.30M | ||
| Accumulated Retained Earnings (Deficit) | -69.17M | ||
| Shareholders Equity | 48.97M | ||
| Shareholders Equity (USD) | 48.97M | ||
| Assets Non-Current | 8.42K | ||
| Deferred Revenue | 2.00M | ||
| Liabilities Non-Current | 754.20K | ||
| Trade and Non-Trade Payables | 948.19K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.81K | ||
| Net Cash Flow from Financing | 11.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.90M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -885.00K | ||
| Issuance (Purchase) of Equity Shares | 11.00M | ||
| Net Cash Flow from Investing | -885.00K | ||
| Net Cash Flow from Operations | -6.21M | ||
| Share Based Compensation | 2.20M | ||